Fritz Janicke
Overview
Explore the profile of Fritz Janicke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
2418
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thomssen C, Vetter M, Kantelhardt E, Meisner C, Schmidt M, Martin P, et al.
Cancers (Basel)
. 2023 Mar;
15(5).
PMID: 36900372
Background: In node-negative breast cancer (NNBC), a high risk of recurrence is determined by clinico-pathological or tumor-biological assessment. Taxanes may improve adjuvant chemotherapy. Methods: NNBC 3-Europe, the first randomized phase-3...
2.
Lebok P, Huber J, Burandt E, Lebeau A, Marx A, Terracciano L, et al.
Mol Med Rep
. 2016 Jul;
14(2):1443-50.
PMID: 27357606
Angiogenesis is a key process in tumor growth and progression, which is controlled by vascular endothelial growth factors (VEGFs) and their receptors (VEGFRs). In order to better understand the prevalence...
3.
Erber R, Gluz O, Brunner N, Kreipe H, Pelz E, Kates R, et al.
Breast Cancer Res Treat
. 2015 Feb;
150(2):279-88.
PMID: 25721604
Taxane-anthracycline-based adjuvant chemotherapy is standard of care in patients with node-positive breast cancer (BC) but is also associated with severe side effects and significant costs. It is yet unclear, which...
4.
Witzel I, Milde-Langosch K, Schmidt M, Karn T, Becker S, Wirtz R, et al.
Onco Targets Ther
. 2014 Dec;
7:2205-13.
PMID: 25506225
Background: Protein levels of urokinase plasminogen activator (uPA) and its inhibitor (PAI-1) determined by enzyme-linked immunosorbent assay from fresh-frozen tumor tissue have been evaluated as prognostic factors in prospectively randomized...
5.
Witzel I, Muller V, Abenhardt W, Kaufmann M, Schoenegg W, Schneeweis A, et al.
BMC Cancer
. 2014 Nov;
14:806.
PMID: 25371387
Background: In this study, we examined patients who had non-progressive disease for at least 2 years after diagnosis of inoperable locoregional recurrent or metastatic breast cancer under continuous trastuzumab treatment....
6.
Burandt E, Bari Noubar T, Lebeau A, Minner S, Burdelski C, Janicke F, et al.
Oncol Rep
. 2014 Oct;
32(6):2628-34.
PMID: 25270339
Activated leukocyte cell adhesion molecule (ALCAM) is a membranous cell adhesion protein that is often expressed in breast cancer. Data on the prognostic impact of ALCAM expression is highly controversial...
7.
Burandt E, Grunert M, Lebeau A, Choschzick M, Quaas A, Janicke F, et al.
Breast Cancer
. 2014 May;
23(1):111-119.
PMID: 24862872
Background: Cyclin D1 (CCND1) gene amplification is a molecular key alteration in breast cancer and was suggested to predict resistance to antihormonal therapy. As tissue heterogeneity may affect diagnostic accuracy...
8.
Untch M, Gerber B, Harbeck N, Jackisch C, Marschner N, Mobus V, et al.
Breast Care (Basel)
. 2014 Jan;
8(3):221-9.
PMID: 24415975
The International Consensus Conference on the treatment of primary breast cancer takes place every two years in St. Gallen, Switzerland. The panel in St. Gallen is composed of international experts...
9.
Burandt E, Schreiber M, Stein A, Minner S, Clauditz T, Bokemeyer C, et al.
Genes Chromosomes Cancer
. 2013 Dec;
53(3):228-39.
PMID: 24311521
In cancer therapy, the number of drugs targeting cells with characteristic molecular aberrations is continuously rising. However, application of these new drugs still is limited to a few tumor entities....
10.
Eckhoff K, Flurschutz R, Trillsch F, Mahner S, Janicke F, Milde-Langosch K
J Cancer Res Clin Oncol
. 2013 Aug;
139(10):1673-80.
PMID: 23942796
Purpose: The Jun proteins (c-Jun, JunD and JunB) play an important role in the regulation of cell proliferation, apoptosis and angiogenesis. It is well established that these proteins participate in...